TRCT
SBII.U

Tower Research Capital (TRC)’s Sandbridge X2 Corp. Units, each consisting of one share of Class A common stock and one-third of one redeemable warrant SBII.U Stock Holding History

Tower Research Capital (TRC)’s Portfolio SBII.U Stock Details SBII.U Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-74
Closed -$1K – 6840
2022
Q3 		$1K Sell
74
-50
-40% -$491 ﹤0.01% 5980
2022
Q2 		$1K Buy
+124
New +$1.22K ﹤0.01% 5995
2021
Q3 		– Sell
-100
Closed -$1K – 6445
2021
Q2 		$1K Buy
+100
New +$1K ﹤0.01% 5351

Tower Research Capital (TRC)'s SBII.U Position: Q4 2022 in Review

Tower Research Capital (TRC) sold out of Sandbridge X2 Corp. Units, each consisting of one share of Class A common stock and one-third of one redeemable warrant (SBII.U) in Q4 2022, closing a stake of 74 shares — an estimated $1K sold.

Tower Research Capital (TRC) first reported a position in SBII.U in Q2 2021 and held it in 3 quarters. The position peaked at $1K in Q3 2022. 0 funds tracked by Wall St. Rank hold SBII.U as of Q4 2022.

  • Tower Research Capital (TRC) reported no remaining Sandbridge X2 Corp. Units, each consisting of one share of Class A common stock and one-third of one redeemable warrant position as of Q4 2022 after selling out during the quarter.
  • Tower Research Capital (TRC) sold 74 Sandbridge X2 Corp. Units, each consisting of one share of Class A common stock and one-third of one redeemable warrant shares in Q4 2022, an estimated $1K.
  • Tower Research Capital (TRC) first reported a position in Sandbridge X2 Corp. Units, each consisting of one share of Class A common stock and one-third of one redeemable warrant in Q2 2021 and held it in 3 quarters.
  • Tower Research Capital (TRC)'s Sandbridge X2 Corp. Units, each consisting of one share of Class A common stock and one-third of one redeemable warrant position peaked at $1K in Q3 2022.
  • 0 funds tracked by Wall St. Rank held Sandbridge X2 Corp. Units, each consisting of one share of Class A common stock and one-third of one redeemable warrant as of Q4 2022.

Based on Tower Research Capital (TRC)'s 13F filing for Q4 2022, filed 10 Feb 2023.